Omeprazole 20mg + Domperidone 10mg
Omeprazole 20mg (irreversible H⁺/K⁺-ATPase proton pump inhibition) + Domperidone 10mg (peripheral D2/D3 receptor antagonism, prokinetic + anti-emetic). The 10mg immediate-release domperidone provides prokinetic coverage without the prolonged SR profile of the 30mg SR formulations used in SOUNDRAB™ DSR — appropriate for patients requiring less sustained prokinetic action or for twice-daily dosing where 30mg SR would provide excessive dopamine blockade. See OMEKEY 20 and PANSWING™ LS for full component mechanisms.
GORD with mild-moderate gastroparesis, functional dyspepsia with acid and motility components, nausea associated with peptic disease, post-prandial bloating with reflux. The 10mg immediate-release domperidone is preferred when prokinetic therapy is required at meal times only rather than sustained throughout the day.
Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.
OMEKEY D provides the accessible entry point in the OMEKEY™ brand range — combining the foundational omeprazole 20mg with immediate-release domperidone 10mg at a lower MRP than the SR combination products. For cost-sensitive prescribing environments where the full SR prokinetic profile is not clinically required, OMEKEY D delivers the core functional dyspepsia treatment at a practical price point.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.